0001952448-25-000004.txt : 20251210 0001952448-25-000004.hdr.sgml : 20251210 20251209200200 ACCESSION NUMBER: 0001952448-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251210 DATE AS OF CHANGE: 20251209 EFFECTIVENESS DATE: 20251210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Liberation Bioindustries, Inc. CENTRAL INDEX KEY: 0001952448 ORGANIZATION NAME: EIN: 882720388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566313 FILM NUMBER: 251560550 BUSINESS ADDRESS: STREET 1: 80 BROAD STREET STREET 2: 5TH FLOOR, PMB#6450 CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 917-539-8620 MAIL ADDRESS: STREET 1: 80 BROAD STREET STREET 2: 5TH FLOOR, PMB#6450 CITY: NEW YORK STATE: NY ZIP: 10004 FORMER COMPANY: FORMER CONFORMED NAME: Liberation Labs Holdings Inc. DATE OF NAME CHANGE: 20221028 D 1 primary_doc.xml X0708 D LIVE 0001952448 Liberation Bioindustries, Inc. 14 Wall Street 20th Floor NEW YORK NY NEW YORK 10005 917-539-8620 DELAWARE Liberation Labs Holdings Inc. Corporation true 2022 Mark Warner 14 Wall Street 20th Floor New York NY NEW YORK 10005 Executive Officer Director James Mellon 14 Wall Street 20th Floor New York NY NEW YORK 10005 Director Babar Khan 14 Wall Street 20th Floor New York NY NEW YORK 10005 Director Steven Finn 14 Wall Street 20th Floor New York NY NEW YORK 10005 Director Philip Boigner 14 Wall Street 20th Floor New York NY NEW YORK 10005 Director Etan Bendheim 14 Wall Street 20th Floor New York NY NEW YORK 10005 Executive Officer Other Technology Decline to Disclose 06b false 2025-11-24 false true false 0 101664354 60164351 41500003 $56,664,354 of the Total Amount Sold was accounted for by the conversion of existing convertible notes. The remainder of the Total Amount Sold was accounted for by new cash investments. false 7 0 0 0 false Liberation Bioindustries, Inc. /s/ Mark Warner Mark Warner CEO 2025-12-09